← Back to Search

Educational Intervention for Lung Cancer

N/A
Waitlist Available
Led By Elizabeth Bouchard
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Members of all races and ethnic groups are eligible for this study
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

This study is evaluating whether a program can improve knowledge about lung cancer screening.

Eligible Conditions
  • Lung Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average number of attendees at each site
Change in fear, worry, and increased health-related self-efficacy
Demographics of attendees at each site
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Prevention (AIR Program)Experimental Treatment2 Interventions
Participants complete the Roswell Awareness, Information and Resources for Lung Cancer Screening (AIR) Program over 45 minutes and then receive the High-Risk Lung Cancer Tip Sheet..
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Intervention
2013
N/A
~7220
Questionnaire Administration
2016
Completed Phase 3
~5140

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
30,515 Total Patients Enrolled
Elizabeth BouchardPrincipal InvestigatorRoswell Park Cancer Institute
2 Previous Clinical Trials
109 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~67 spots leftby Apr 2025